Equillium Investor Presentation Deck
February 2024, 40 slides
  1. Equillium
  2. Related Decks
  3. Investor Presentation Decks
corporate presentation | Equillium
forward looking statements | Equillium
snapshot investment highlights leaders in developing high impact novel therapeutics to treat and inflammatory disorders assets | Equillium
diversified pipeline of first in class immunology assets first class | Equillium
first in class immune modifying targeting the signaling pathway | Equillium
pharmaceutical high value strategic partnership | Equillium
driving development towards option decision two data deliverables expected in data deliverables and option decision expected during | Equillium
platform therapeutic candidates | Equillium
are validated drug targets | Equillium
challenges in targeting signaling | Equillium
inhibitor platform | Equillium
receptor a key shared signaling hub | Equillium
generation of selective inhibitors | Equillium
disrupting assembly of the receptor complex | Equillium
the inhibitor advantage | Equillium
first in class tri specific inhibitor of tri | Equillium
first in class tri specific inhibitor tri | Equillium
valuable medical dermatology franchise | Equillium
more complete downstream signal inhibition versus | Equillium
clinically validated in severe dermatological disease | Equillium
positive proof of concept opens up indication expansion | Equillium
targeted treatment approach for alopecia | Equillium
reverses immune mediated hair loss in a mouse model | Equillium
salt response varies based on severity | Equillium
large unmet need in alopecia for my patients | Equillium
phase study of in adults with moderate to severe potential target product profile alternative to with at least comparable efficacy patient administered weekly weekly subcutaneous injection similar to | Equillium
first in class orally delivered specific inhibitor of | Equillium
first in class specific inhibitor i | Equillium
valuable gastrointestinal franchise | Equillium
no approved therapies for celiac disease celiac disease billion dollar annual market opportunity me | Equillium
celiac disease destructive immune mediated disease | Equillium
a targeted treatment approach for celiac disease | Equillium
opportunity in celiac disease promote | Equillium
competitive landscape in celiac disease by | Equillium
corporate | Equillium
accomplished executive leadership | Equillium
intellectual property regulatory exclusivity | Equillium
financial overview | Equillium
milestones | Equillium
thank you a | Equillium
See More
Equillium
Investor Presentation Decks
Biotechnology Decks
Healthcare Decks
Explore Topics
Inhibitor
Inflammation
Recent decks by Equillium
Investor Presentation
December 2023
Investor Presentation
November 2023
Investor Presentation
August 2023
Results
September 2022
See all presentations by Equillium (5 decks)
Related decks
Third Harmonic Bio
Investor Presentation
October 2022
NeuroBo Pharmaceuticals
Investor Presentation
January 2024
Relay Therapeutics
IPO
July 2020
Nuvectis Pharma
Investor Presentation
July 2023
Exscientia
Investor Day
January 2024
BenevolentAI
Investor Presentation
October 2022
Alkermes
Investor Day
March 2021
AstraZeneca
Results
July 2021
Recent decks by Equillium
See all presentations (5 decks)
Investor Presentation
December 2023
Investor Presentation
November 2023
Investor Presentation
August 2023
Results
September 2022
Third Harmonic Bio
Investor Presentation
October 2022
NeuroBo Pharmaceuticals
Investor Presentation
January 2024
Relay Therapeutics
IPO
July 2020
Nuvectis Pharma
Investor Presentation
July 2023
Exscientia
Investor Day
January 2024
BenevolentAI
Investor Presentation
October 2022
Alkermes
Investor Day
March 2021
AstraZeneca
Results
July 2021
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2024 Slidebook.io